Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Express Scripts
Harvard Business School
Mallinckrodt
Merck

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Bacampicillin hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for bacampicillin hydrochloride and what is the scope of freedom to operate?

Bacampicillin hydrochloride is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for bacampicillin hydrochloride.

Summary for bacampicillin hydrochloride
Recent Clinical Trials for bacampicillin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
James Graham Brown Cancer CenterPhase 0
University of LouisvillePhase 0
Julio RamirezPhase 0

See all bacampicillin hydrochloride clinical trials

Synonyms for bacampicillin hydrochloride
(2S,5R,6R)-1-(ethoxycarbonyloxy)ethyl 6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-((R)-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with ethyl 1-hydroxyethyl carbonate, monohydrochloride
(2S,5R,6R)-6-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 1-ethoxycarbonyloxyethyl ester
(2S,5R,6R)-6-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 1-ethoxycarbonyloxyethyl ester hydrochloride
(2S,5R,6R)-6((R)-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with ethyl 1-hydroxyethylcarbonate
1-((Ethoxycarbonyl)oxy)ethyl (2S-(2alpha,5alpha,6beta(S*)))-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrochloride
1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-[(ethoxycarbonyl)oxy]ethyl 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylate
1-[(ethoxycarbonyl)oxy]ethyl 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylate hydrochloride
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
1-Ethoxycarbonyloxyethyl (2S,5R,6R)-6((R)-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carboxylat
1'-Ethoxycarbonyloxyethyl-(6-D-alpha-aminophenylacetamido)penicillanate
37661-08-8
37661-08-8 (mono-hydrochloride)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, (2S-(2alpha,5alpha,6beta(S*)))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, hydrochloride
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, monohydrochloride, (2S-(2alpha,5alpha,6beta(S*)))-
50972-17-3
50972-17-3 (Parent)
6-((R)-2-Amino-2-phenylacetamido)penicillansaeure-(1-(ethoxycarbonyloxy)ethylester
A823813
A828376
AC1L9B3D
AC1L9B3G
AKOS016014246
AKOS030526153
Ambacamp
Ambaxin
API0000413
AX8020538
Bacacil
Bacampicilina
Bacampicilina [INN-Spanish]
bacampicillin
Bacampicillin (hydrochloride)
Bacampicillin (INN)
Bacampicillin [INN:BAN]
bacampicillin HCl
Bacampicillin hydrochloride (JP17/USP)
Bacampicillin hydrochloride [USAN:USP:JAN]
Bacampicillin hydrochoride
Bacampicilline
Bacampicilline [INN-French]
bacampicillinum
Bacampicillinum [INN-Latin]
BAPC
BPBio1_000410
BRD-A41698174-003-03-9
BSPBio_000372
C-22644
C08122
C08123
C21H27N3O7S.HCl
CAS-37661-08-8
CC-24236
CCG-220416
CHEBI:2968
CHEBI:2969
CHEMBL1200965
CHEMBL1583
CS-4753
CS-4754
D00927
D07487
DB01602
DSSTox_CID_25466
DSSTox_GSID_45466
DSSTox_RID_80897
DTXSID0045466
DTXSID2048030
EINECS 253-580-4
Epitope ID:117129
HMS1569C14
HY-B1149
HY-B1149A
IWVTXAGTHUECPN-ANBBSHPLSA-N
MLS002153801
MolPort-019-996-595
NCGC00016837-01
NCGC00179582-01
NCGC00179582-03
Penglobe
Penglobe (TN)
PFOLLRNADZZWEX-FFGRCDKISA-N
Prestwick_776
Prestwick0_000416
Prestwick1_000416
Prestwick2_000416
Prestwick3_000416
SCHEMBL124593
SCHEMBL33818
SMR001233177
SPBio_002311
Spectrobid
Spectrobid (TN)
SureCN721373
Tox21_110640
Tox21_110640_1
Velbacil

US Patents and Regulatory Information for bacampicillin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer SPECTROBID bacampicillin hydrochloride FOR SUSPENSION;ORAL 050556-001 Mar 23, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer SPECTROBID bacampicillin hydrochloride TABLET;ORAL 050520-002 Sep 12, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer SPECTROBID bacampicillin hydrochloride TABLET;ORAL 050520-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKinsey
Baxter
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.